These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1373542)

  • 1. Cytoprotective effect of CD59 antigen on xenotransplantation immunity.
    Akami T; Sawada R; Minato N; Naruto M; Yamada A; Imanishi J; Mitsuo M; Nakai I; Okamoto M; Nakajima H
    Transplant Proc; 1992 Apr; 24(2):485-7. PubMed ID: 1373542
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of human CD59 antigen in discordant xenotransplantation between humans and nonprimates.
    Akami T; Arakawa K; Okamoto M; Sawada R; Naruto M; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):394-5. PubMed ID: 7679814
    [No Abstract]   [Full Text] [Related]  

  • 3. CD46 (MCP) confers protection from lysis by xenogeneic antibodies.
    Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):396-7. PubMed ID: 8438351
    [No Abstract]   [Full Text] [Related]  

  • 4. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
    Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
    Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional expression of human CD59 in transgenic mice.
    Somerville CA; Kyriazis AG; McKenzie A; Allison J; Pearse MJ; D'Apice AJ
    Transplantation; 1994 Dec; 58(12):1430-5. PubMed ID: 7528953
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid transformant selection by human complement using HRF20 (CD59) cDNA as a selection marker.
    Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
    Eur J Immunol; 1993 Oct; 23(10):2714-6. PubMed ID: 7691615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
    Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
    Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part II: xenogeneic perfusion of the porcine liver in vivo.
    Shiraishi M; Oshiro T; Nozato E; Nagahama M; Taira K; Nomura H; Sugawa H; Muto Y
    Transpl Int; 2002 May; 15(5):212-9. PubMed ID: 12012041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
    [No Abstract]   [Full Text] [Related]  

  • 10. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
    Capey S; van den Berg CW
    Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
    Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
    Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional feature of C5b-8-step lysis of swine endothelial cell- transfected CD59.
    Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Matsuda H; Terado A; Hatanaka M; Matsumoto M; Seya T
    Transplant Proc; 1996 Apr; 28(2):597-8. PubMed ID: 8623293
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of the complement regulatory function of CD59 by site-directed mutagenesis at the N-glycosylation site.
    Akami T; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Nakai I; Mitsuo M; Sawada R; Naruto M; Oka T
    Transplant Proc; 1994 Jun; 26(3):1256-8. PubMed ID: 7518124
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
    Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB
    Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from complement-mediated cytolysis in cross-species hepatocytes transfected with complement regulatory factor (HRF20) using retroviral vector.
    Hayashi S; Isobe K; Emi N; Kasai Y; Yokoyama I; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1252. PubMed ID: 7518121
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of species-specific complement-mediated cytolysis in xenoendothelial cells transfected with GPI-anchored complement regulatory factor (DAF, HRF20) gene using retroviral vector: comparison between single (DAF or HRF20) and double (DAF and HRF20) transfected xenoendothelial cells.
    Hayashi S; Isobe K; Emi N; Yokoyama I; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1243-4. PubMed ID: 7518119
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium.
    Miyagawa S; Shirakura R; Izutani H; Matsumiya G; Nakata S; Matsuda H; Iwata K; Nagasawa S; Terado A; Matsumoto M
    Transplant Proc; 1994 Jun; 26(3):1253-4. PubMed ID: 7518122
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular characterization of the polymorphic expression of CD46: a cell surface molecule protecting cells from complement attack.
    Russell SM; Johnstone RW; Wilton A; Sparrow RL; McKenzie IF; Purcell DF
    Transplant Proc; 1992 Feb; 24(1):211-3. PubMed ID: 1539251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.